期刊文献+

首发为血液系统表现的骨髓转移癌39例分析 被引量:3

下载PDF
导出
摘要 目的了解首发为血液系统表现的骨髓转移癌患者的临床表现和外周血常规及骨髓细胞形态学特点,提高对该疾病的诊断水平。方法回顾分析39例骨髓转移癌患者的临床表现、血常规及骨髓特点。结果 39例骨髓转移癌患者临床症状以骨痛(66.67%)、贫血(71.79%)、发热(38.46%)最常见,骨髓涂片尾部或边缘见转移癌细胞,原发灶不明转移癌占38.46%,其次为肺癌、前列腺癌、胃癌、乳腺癌等。结论对于临床上出现不明原因的贫血、骨痛、发热等症状的患者,应考虑到骨髓转移癌可能,及时作骨髓穿刺或骨髓活检,正确辨别骨髓转移癌细胞形态特点是提高诊断的关键。
作者 陆作洁
出处 《检验医学与临床》 CAS 2013年第7期841-842,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献5

二级参考文献22

  • 1郝晓,张凤晓,刘玉珍.骨髓转移瘤(附15例临床分析)[J].河北医学院学报,1993,14(2):111-112. 被引量:3
  • 2潘峰.恶性肿瘤的骨髓转移[J].国外医学(肿瘤学分册),1995,22(3):145-147. 被引量:33
  • 3袁菲,肖家诚,金晓龙,缪飞,熊树民,黄婷.骨髓活检在转移性癌病理诊断中的作用[J].上海交通大学学报(医学版),2006,26(5):444-447. 被引量:6
  • 4Denielle S, Vincenzo L, Angelo CR, et al. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PIZF/RARA gene rearrangements[J]. Blood, 2000,96(4):1287.
  • 5范郎娣主编.王德延肿瘤病理诊断学(上册).天津:天津科学技术出版社,1999.
  • 6Foucar K.Bone marrow pathology.Chicago:ASCP Integrative Hematopathology,1995.442~443
  • 7Frisch B,Lewis S M,Burkhardt R,et al.Biopsy pathology of bone and bonemarrow.London:Chapman and Hall Medical,1985.243~275
  • 8Machicao C N,Schaub C R,Farhi D C.Circulating mucin in breast carcinoma andautomated leukocyte counts.Hematol Pathol,1988,2:159~161
  • 9Aloulafia D M.Carcinocythemia.A terminal manife-station of metastatic breastcancer. West J Med,1992,157:672~674 (收稿 1999-10-28)
  • 10YUN HK, SHIN MG, BO D, et al. Laboratory evaluation of bone marrow metastasis : single institute study [J]. Korean J Lab Med, 2007,27(2) :96-101.

共引文献71

同被引文献25

  • 1Michiya Kobayashi,Takehiro Okabayashi,Takeshi Sano,Keijiro Araki.Metastatic bone cancer as a recurrence of early gastric cancer - characteristics and possible mechanisms[J].World Journal of Gastroenterology,2005,11(36):5587-5591. 被引量:10
  • 2常晓松,甄鹏,曾健,张素娟,王爱东,胡志华,张永军.胃癌术后3年骨髓转移一例[J].肿瘤研究与临床,2006,18(11):752-752. 被引量:1
  • 3Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity' s roles in cancer suppression and pro- motion[J]. Science, 2011, 331(6024): 1565-1570.
  • 4Movahedi K, Guilliams M, Van den Bossche J, et al. Iden- tification of discrete tumor-induced myeloid- derived sup- pressor cell subpopulations with distinct T cell-suppressive activity [ J ]. Blood, 2008,111 (8) :4233-4244.
  • 5Jessiea B. Katz, Alexander J. Muller, GeorgeC. Prendergast In- doleamine 2, 3- dioxygenasein Teell toleranee and tumoral immunee sea[ J] .Immunologieal Reviews,2008, (222) : 206 -221.
  • 6Baban B, Chandler PR, Sharma MD, et al. IDO activates regulatory T ceils and blocks their conversion into Th17-like T cells[J]. Immunol, 2009, 183(4): 2475-2483.
  • 7Godin-Ethier J, Hanafi LA, Piccirillo CA, et al. Indoleam- ine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives [ J ]. Clin Cancer Res, 2011, 17(22) : 6985-6991.
  • 8Kusmartsev S, Su Z, Heiser A, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma[ J].Clin Cancer Res, 2008, 14(24): 8270-8278.
  • 9李莉,王华庆,刘贤明,张会来,邱立华,钱正子.以骨髓转移为首发表现的4例胃癌的临床分析[J].临床肿瘤学杂志,2008,13(10):931-933. 被引量:8
  • 10匡洁,丁家增,杨卫平,朱正纲.以血小板减少和贫血为主要表现的胃癌骨转移的临床分析[J].上海交通大学学报(医学版),2009,29(1):116-118. 被引量:6

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部